1. Home
  2. REVB vs SGLY Comparison

REVB vs SGLY Comparison

Compare REVB & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.63

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Singularity Future Technology Ltd.

SGLY

Singularity Future Technology Ltd.

HOLD

Current Price

$0.68

Market Cap

5.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
SGLY
Founded
2020
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
REVB
SGLY
Price
$0.63
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3M
762.5K
Earning Date
03-05-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,619,679.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.45
52 Week High
$17.04
$3.71

Technical Indicators

Market Signals
Indicator
REVB
SGLY
Relative Strength Index (RSI) 30.42 49.26
Support Level $0.71 $0.45
Resistance Level $0.96 $1.02
Average True Range (ATR) 0.14 0.09
MACD -0.01 0.00
Stochastic Oscillator 4.73 18.33

Price Performance

Historical Comparison
REVB
SGLY

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: